| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.37 | 1e-20 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.26 | 3e-15 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-14 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.24 | 2e-14 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.22 | 5e-12 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-11 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-11 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-11 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.22 | 9e-11 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-10 |